Wang J, Logovinsky V, Hendrix SB, Stanworth SH, Perdomo C, Xu L, Dhadda S, Do I, Rabe M, Luthman J, Cummings J, Satlin A. ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials. J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):993-9. Epub 2016 Mar 23 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Leqembi

News

  1. Drug Trials in Frontotemporal Dementia: Can Field Push Forward Together?
  2. Playing Where the Puck Is Going to Be: Trial Sites Skate Toward GAP Net, EPAD TDCs
  3. Planning the First Primary Prevention Trial for Alzheimer’s Disease
  4. No Man’s Land: Neither Early Success nor Failure for BAN2401
  5. Hanging in There: Another BACE Inhibitor Still Safe in Phase 2
  6. Topline Results: 18 Months of BAN2401 Might Work
  7. BAN2401 Removes Brain Amyloid, Possibly Slows Cognitive Decline
  8. Which Are the Right Tests to Satisfy New FDA Guidance?

Research Timeline Event

  1. Cognitive composites developed to track preclinical AD